文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

低密度脂蛋白:用于靶向递送的多功能纳米级平台。

Low-density lipoprotein: a versatile nanoscale platform for targeted delivery.

作者信息

Dai Luyao, Li Shuaijun, Hao Qian, Zhou Ruina, Zhou Hui, Lei Wenxi, Kang Huafeng, Wu Hao, Li Yuanpei, Ma Xiaobin

机构信息

Department of Oncology, The Second Affiliated Hospital, Medical School of Xi'an Jiaotong University Xi'an Shaanxi 710061 China.

Department of Biophysics, School of Basic Medical Sciences, Key Laboratory of Environment and Genes Related to Diseases, Xi'an Jiaotong University Health Science Center Xi'an Shaanxi 710061 China.

出版信息

Nanoscale Adv. 2023 Jan 24;5(4):1011-1022. doi: 10.1039/d2na00883a. eCollection 2023 Feb 14.


DOI:10.1039/d2na00883a
PMID:36798503
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9926902/
Abstract

Low-density lipoprotein (LDL) is a small lipoprotein that plays a vital role in controlling lipid metabolism. LDL has a delicate nanostructure with unique physicochemical properties: superior payload capacity, long residence time in circulation, excellent biocompatibility, smaller size, and natural targeting. In recent decades, the superiority and feasibility of LDL particles as targeted delivery carriers have attracted much attention. In this review, we introduce the structure, composition, advantages, defects, and reconstruction of LDL delivery systems, summarize their research status and progress in targeted diagnosis and therapy, and finally look forward to the clinical application of LDL as an effective delivery vehicle.

摘要

低密度脂蛋白(LDL)是一种小脂蛋白,在控制脂质代谢中起着至关重要的作用。LDL具有精细的纳米结构,具有独特的物理化学性质:高负载能力、在循环中的长停留时间、优异的生物相容性、较小的尺寸和天然靶向性。近几十年来,LDL颗粒作为靶向递送载体的优越性和可行性备受关注。在这篇综述中,我们介绍了LDL递送系统的结构、组成、优点、缺陷和改造,总结了它们在靶向诊断和治疗方面的研究现状和进展,最后展望了LDL作为有效递送载体的临床应用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/42ad/9926902/beadaf55ce9d/d2na00883a-f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/42ad/9926902/312f992edfc3/d2na00883a-f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/42ad/9926902/6712be347515/d2na00883a-f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/42ad/9926902/eca55669ffac/d2na00883a-f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/42ad/9926902/f3755433d049/d2na00883a-f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/42ad/9926902/beadaf55ce9d/d2na00883a-f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/42ad/9926902/312f992edfc3/d2na00883a-f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/42ad/9926902/6712be347515/d2na00883a-f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/42ad/9926902/eca55669ffac/d2na00883a-f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/42ad/9926902/f3755433d049/d2na00883a-f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/42ad/9926902/beadaf55ce9d/d2na00883a-f5.jpg

相似文献

[1]
Low-density lipoprotein: a versatile nanoscale platform for targeted delivery.

Nanoscale Adv. 2023-1-24

[2]
Preparation of Lipid Nanodisks Containing Apolipoprotein E-Derived Synthetic Peptides for Biocompatible Delivery Vehicles Targeting Low-Density Lipoprotein Receptor.

Biol Pharm Bull. 2019

[3]
Enhanced blood-brain barrier penetration and glioma therapy mediated by T7 peptide-modified low-density lipoprotein particles.

Drug Deliv. 2018-11

[4]
Synthetic lipoprotein as nano-material vehicle in the targeted drug delivery.

Drug Deliv. 2017-12

[5]
A high-density lipoprotein-mediated drug delivery system.

Adv Drug Deliv Rev. 2016-5-18

[6]
Low-density lipoprotein nanomedicines: mechanisms of targeting, biology, and theranostic potential.

Drug Deliv. 2021-12

[7]
Tumor-targeted delivery of paclitaxel using low density lipoprotein-mimetic solid lipid nanoparticles.

Mol Pharm. 2015-4-6

[8]
Lipoprotein-Related and Apolipoprotein-Mediated Delivery Systems for Drug Targeting and Imaging.

Curr Med Chem. 2015

[9]
Low-density lipoprotein-decorated and Adriamycin-loaded silica nanoparticles for tumor-targeted chemotherapy of colorectal cancer.

Adv Clin Exp Med. 2019-4

[10]
Synthetic nano-low density lipoprotein as targeted drug delivery vehicle for glioblastoma multiforme.

Int J Pharm. 2007-1-2

引用本文的文献

[1]
Lipoprotein receptors: A little grease for enveloped viruses to open the lock?

J Biol Chem. 2024-11

[2]
Research Hotspots and Development Trends on Apolipoprotein B in the Field of Atherosclerosis: A Bibliometric Analysis.

Mol Biotechnol. 2025-6

[3]
Photodynamic Therapy and Cardiovascular Diseases.

Int J Mol Sci. 2024-3-4

[4]
Prevention of Colitis-Associated Cancer via Oral Administration of M13-Loaded Lipid Nanoparticles.

Pharmaceutics. 2023-9-16

本文引用的文献

[1]
On-demand targeting nanotheranostics with stimuli-responsive releasing property to improve delivery efficiency to cancer.

Biomaterials. 2022-11

[2]
Lipoprotein interactions with water-soluble NIR-II emitting aza-BODIPYs boost the fluorescence signal and favor selective tumor targeting.

Biomater Sci. 2022-10-25

[3]
Low-density lipoprotein encapsulated thiosemicarbazone metal complexes is active targeting vehicle for breast, lung, and prostate cancers.

Drug Deliv. 2022-12

[4]
Tumor-Activatable Nanoparticles Target Low-Density Lipoprotein Receptor to Enhance Drug Delivery and Antitumor Efficacy.

Adv Sci (Weinh). 2022-8

[5]
Proteomic studies on apoB-containing lipoprotein in cardiovascular research: A comprehensive review.

Mass Spectrom Rev. 2023

[6]
LDL mediated delivery of Paclitaxel and MRI imaging probes for personalized medicine applications.

J Nanobiotechnology. 2021-7-13

[7]
LDL-mimetic lipid nanoparticles prepared by surface KAT ligation for MRI of atherosclerosis.

Chem Sci. 2020-10-7

[8]
Transporting mitochondrion-targeting photosensitizers into cancer cells by low-density lipoproteins for fluorescence-feedback photodynamic therapy.

Nanoscale. 2021-1-14

[9]
Biophysical, Biochemical, and Behavioral Implications of ApoE3 Conjugated Donepezil Nanomedicine in a Aβ Induced Alzheimer's Disease Rat Model.

ACS Chem Neurosci. 2020-12-16

[10]
Elevated LDL cholesterol and increased risk of myocardial infarction and atherosclerotic cardiovascular disease in individuals aged 70-100 years: a contemporary primary prevention cohort.

Lancet. 2020-11-21

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索